Vaccines: Purchases from Russia up 54% in 2020During 2020, companies in the region allocated $134 million for the import of vaccines for human use, and purchases from Russian companies increased 54% over what was reported in 2019.Friday, June 11, 2021 Vaccine for Human Use Imports in Central America Al June 30th, 2021
CentralAmericaDataINFORMACIÓN DE MERCADOS
Complete el formulario, en breve nos comunicaremos con usted:Need assistance? Contact us
(506) 4001-6423
CentralAmericaData is the leading B2B market research company in Central America. We specialize in compiling, validating and analyzing data from the economic activities in Central American and South American countries, along with Mexico. We provide our clients and companies with presence in the region relevant information to define business strategies and make adequate decisions. Learn more about our services here 2008 - 2022 © CentralAmericaData Todos los derechos reservados
Figures from the Trade Intelligence Unit of CentralAmericaData: Click to interact with the graph Do you need Business Intelligence solutions for the medical products market? Contact UsNeed assistance? Contact us
(506) 4001-6423
Medicines: Purchases Exceed $3.5 BillionMay 2021 During 2020, Central American imports of pharmaceutical products totaled $3.502 billion, and purchases from Mexican companies increased by 2% over the amount reported in 2019. Human Vaccines: Business with Russia is IncreasingMarch 2021 From January to September 2020, companies in the region invested $101 million for the purchase abroad of vaccines for human use, and purchases from Russian companies increased 34% compared to the same period in 2019. Vaccines for Human Use: Business in the RegionSeptember 2020 From January to March 2020, companies in the region bought vaccines for human use abroad for $28 million, and 56% of total imports were made by companies in Costa Rica and Panama. Vaccines: Purchases Up 11% in 2018June 2019 In 2018, purchases of vaccines for human use in Central America totaled $141 million, 11% more than reported in 2017.
×
|
|